Stock listing
Theralink Technologies Inc.
Selected listing: THER · OTC · USD · US
Theralink Technologies Inc. (OTC:THER), Health Technology. Latest release Sep 27, 2018: OncBioMune Initiates Phase 2 Clinical Trial of Novel Vaccine…
- Ticker
- OTC:THER
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
About Theralink Technologies Inc.
Theralink Technologies Inc. is a public company traded under the ticker THER in the American market. Theralink focuses on advancing technologies in the healthcare sector, specifically in the field of personalized medicine.
Latest news from Theralink Technologies Inc.
OncBioMune Initiates Phase 2 Clinical Trial of Novel Vaccine as Front-Line Treatment for Prostate Cancer
September 27, 2018
OncBioMune’s Phase 2 Clinical Trial of ProscaVax for Early-Stage Prostate Cancer is Now Included on ClinicalTrials.gov
July 9, 2018
OncBioMune Signs Work Order for Phase 2 Clinical Trial of ProscaVax for Early Stage Prostate Cancer
July 2, 2018
OncBioMune to Commence Phase 2 Trial of ProscaVax for Early Stage Prostate Cancer Patients
June 20, 2018
OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor Designations for the Month of May
June 6, 2018
Research Theralink Technologies Inc.
Theralink Technologies Inc. company profile
View the public company page for Theralink Technologies Inc. on 6ix.
Theralink Technologies Inc. news
Read company news and market updates connected to Theralink Technologies Inc..
Theralink Technologies Inc. investor events
Find investor webinars, events, and replay context for Theralink Technologies Inc..